Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GY0E
|
|||
| Drug Name |
Benzothiazepine analog 5
|
|||
| Synonyms |
PMID27607364-Compound-71
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H17NO3
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)C2=C(C3=CC=CN3C4=CC=CC=C4O2)OC(=O)C
|
|||
| InChI |
1S/C21H17NO3/c1-14-9-11-16(12-10-14)20-21(24-15(2)23)18-7-5-13-22(18)17-6-3-4-8-19(17)25-20/h3-13H,1-2H3
|
|||
| InChIKey |
SJEIIHOXPXOSSN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
| Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| HTLV-I infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.